Filing Details

Accession Number:
0001209191-18-058716
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-15 16:12:36
Reporting Period:
2018-11-13
Accepted Time:
2018-11-15 16:12:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Albireo Pharma Inc. ALBO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676880 Wilfred Harold Ronald Cooper C/O Albireo Pharma Inc.
10 Post Office Square, Suite 502 South
Boston MA 02109
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-13 1,026 $25.02 7,760 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018.
  2. This transaction was executed in multiple trades at prices ranging from $24.85 to $25.14. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.